Thienopyridazinones and their use in modulation of autoimmune disease

Details for Australian Patent Application No. 2004206011 (hide)

Owner AstraZeneca AB

Inventors Guile, Simon David; Ingall, Anthony Howard

Agent Freehills

Pub. Number AU-B-2004206011

PCT Pub. Number WO2004/065395

Priority 0300118-7 17.01.03 SE; 0300117-9 17.01.03 SE

Filing date 15 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 12 July 2007

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/065395 Priority application(s): WO2004/065395

12 July 2007 Application Accepted

  Published as AU-B-2004206011

8 November 2007 Standard Patent Sealed

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206012-Thienopyrimidinediones and their use in the modulation of autoimmune disease

2004205987-Jackpot wagering with supplementary draw